How should I evaluate and manage a patient with hyponatremia?

Hyponatremia Work-Up

Begin your evaluation by measuring serum sodium, serum osmolality, urine osmolality, and urine sodium, then systematically determine volume status using clinical assessment combined with point-of-care ultrasound to categorize the hyponatremia as hypovolemic, euvolemic, or hypervolemic—this classification directly determines your treatment approach. 1, 2

Initial Laboratory Assessment

When serum sodium drops below 131 mmol/L (some guidelines use <135 mmol/L), immediately obtain:

• Serum osmolality (to confirm hypotonic hyponatremia; normal is 275-295 mOsm/kg)
• Urine osmolality (>100 mOsm/kg suggests impaired water excretion)
• Urine sodium concentration (>20-40 mEq/L indicates renal sodium loss)
• Serum uric acid (<4 mg/dL supports SIADH)
• TSH and cortisol (to exclude hypothyroidism and adrenal insufficiency) 3, 1

Critical distinction: If serum osmolality is normal or high, you're dealing with pseudohyponatremia (hyperglycemia, hypertriglyceridemia, lab error)—not true hyponatremia. Only proceed with hyponatremia workup if osmolality is low (<275 mOsm/kg). 1

Volume Status Assessment: The Key Decision Point

This is where most clinicians struggle, but it's the most critical step. Physical examination alone is unreliable—combine it with objective measures:

Hypovolemic Hyponatremia

Look for:

• Orthostatic hypotension, tachycardia
• Dry mucous membranes, decreased skin turgor
• Urine sodium <20 mEq/L (extrarenal losses: vomiting, diarrhea)
• Urine sodium >20 mEq/L (renal losses: diuretics, cerebral salt wasting, adrenal insufficiency) 1

Euvolemic Hyponatremia

Characterized by:

• No edema, no orthostasis
• Normal skin turgor
• Urine osmolality >100 mOsm/kg (typically >300 mOsm/kg)
• Urine sodium >40 mEq/L
• This is SIADH until proven otherwise (after excluding hypothyroidism, hypocortisolism, polydipsia) 3

Hypervolemic Hyponatremia

Evidence of volume overload:

• Ascites, peripheral edema, pulmonary edema
• Jugular venous distension
• Common in cirrhosis, heart failure, nephrotic syndrome 4

Point-of-care ultrasound significantly improves accuracy: Use lung ultrasound (B-lines), cardiac ultrasound (IVC diameter/collapsibility), and abdominal ultrasound (ascites) to objectively assess volume status. The VExUS score can help identify venous congestion. 5

Severity Classification and Symptom Assessment

Severity determines urgency, not just the sodium number:

Mild (130-134 mEq/L)

• Often asymptomatic or subtle symptoms (weakness, nausea, headache)
• Increased fall risk and cognitive impairment even at this level 2

Moderate (125-129 mEq/L)

• Confusion, general weakness, nausea/vomiting 3

Severe (<125 mEq/L, especially <120 mEq/L)

• Life-threatening: seizures, coma, cardiorespiratory distress, abnormal somnolence
• Requires immediate treatment 4, 3, 1

Acute vs. Chronic matters critically: Acute (<48 hours) hyponatremia causes more severe symptoms and tolerates faster correction. Chronic hyponatremia (>48 hours) requires slower correction to avoid osmotic demyelination syndrome. 1, 2

Specific Diagnostic Algorithms by Volume Status

For Suspected SIADH (Euvolemic)

Must meet ALL criteria:

• Serum sodium <134 mEq/L
• Plasma osmolality <275 mOsm/kg
• Urine osmolality >100 mOsm/kg (usually >300 mOsm/kg)
• Urine sodium >20 mEq/L (typically >40 mEq/L)
• Normal thyroid, adrenal, and renal function
• No diuretic use
• No volume depletion 3

Common causes to investigate: Malignancy (especially small cell lung cancer), CNS disorders, medications (SSRIs, carbamazepine, NSAIDs), pulmonary disease.

For Neurosurgical Patients: SIADH vs. Cerebral Salt Wasting

This distinction is crucial because treatments are opposite:

Cerebral Salt Wasting (CSW):

• Hypovolemia (orthostasis, negative fluid balance)
• High urine sodium (>40 mEq/L) with volume depletion
• Central venous pressure <6 cm H₂O (if available)
• Weight loss, negative sodium balance 1

SIADH:

• Euvolemia (no orthostasis, normal to slightly positive fluid balance)
• High urine sodium but with normal/expanded volume
• CVP 6-12 cm H₂O 1

Pitfall: ADH and natriuretic peptide levels are NOT helpful—they don't reliably distinguish between these conditions. 1

For Cirrhosis Patients

Two distinct types occur:

Hypervolemic hyponatremia (most common):

• Ascites and edema present
• Driven by non-osmotic vasopressin secretion
• Treat when sodium <130 mmol/L 4

Hypovolemic hyponatremia:

• Often NO ascites or edema
• Usually from diuretic overuse or GI losses
• Requires volume expansion 4

Stratified approach for cirrhosis 6, 7:

• Sodium 126-135 mmol/L, normal creatinine: Continue diuretics, monitor closely, NO water restriction
• Sodium 121-125 mmol/L, normal creatinine: Stop or reduce diuretics (controversial—some continue cautiously)
• Sodium 121-125 mmol/L, elevated creatinine (>150 μmol/L): STOP diuretics, give volume expansion
• Sodium <120 mmol/L: STOP diuretics, consider volume expansion with colloid or saline, but avoid rapid correction (max 8 mmol/L per 24 hours)

Management Principles by Category

Hypovolemic Hyponatremia

Treatment: Volume replacement with normal saline (0.9% NaCl). This simultaneously corrects volume deficit and hyponatremia. 1, 8

Euvolemic Hyponatremia (SIADH)

First-line for asymptomatic/mild:

• Fluid restriction to <1 L/day (often ineffective in up to 50% of patients) 3, 1, 9
• Adequate solute intake (salt and protein) 9

Second-line options when fluid restriction fails:

• Oral urea (15-60 g/day)—very effective and safe 9
• Vaptans (tolvaptan, conivaptan)—effective but risk overly rapid correction and increased thirst 4, 3, 2
• Salt tablets
• Demeclocycline or lithium (less commonly used) 3

For severe/symptomatic SIADH: Use hypertonic saline (see below) 1

Hypervolemic Hyponatremia

Primary treatment: Manage underlying condition (heart failure, cirrhosis)

• Sodium restriction (90 mmol/day or 5.2 g salt/day) 6
• Water restriction (1-1.5 L/day) 7
• Diuretic adjustment (may need to reduce or stop) 7
• Consider albumin infusion in cirrhosis 4, 7

Vaptans can be used in heart failure and cirrhosis but only short-term (1 week to 1 month)—long-term use in cirrhosis increased mortality. 4

Emergency Management: Severe Symptomatic Hyponatremia

For seizures, coma, cardiorespiratory distress, or severe altered mental status:

Immediate treatment with 3% hypertonic saline 4, 1, 2:

• Give 100-150 mL IV bolus over 10-20 minutes
• Can repeat 1-2 times if symptoms persist
• Goal: Increase sodium by 4-6 mmol/L within 1-2 hours (just enough to stop symptoms)
• Then SLOW DOWN dramatically

Critical correction limits to prevent osmotic demyelination syndrome:

• First 6 hours: Can correct up to 6 mmol/L if severely symptomatic 1
• First 24 hours: Maximum 8-10 mmol/L total 4, 1, 2
• Subsequent days: Maximum 8 mmol/L per day 4

Monitor sodium every 2 hours initially, then every 4-6 hours. 1

If you overcorrect: Immediately give hypotonic fluids or desmopressin to re-lower sodium. The risk of osmotic demyelination is highest in chronic hyponatremia, alcoholism, malnutrition, and advanced liver disease. 4, 2, 10

Special Populations

Subarachnoid Hemorrhage Patients

• Treat even mild hyponatremia (131-135 mmol/L) due to vasospasm risk
• NEVER fluid restrict—this worsens vasospasm outcomes
• Use hypertonic saline and fludrocortisone for CSW
• Consider hydrocortisone to prevent natriuresis 1

Pre-Liver Transplant Patients

• Hypertonic saline can be used for severe hyponatremia in patients awaiting imminent transplant
• Correct cautiously: 5 mmol/L in first hour, then max 8 mmol/L per 24 hours
• Risk of central pontine myelinolysis is particularly high in advanced cirrhosis 4

Common Pitfalls to Avoid

1. Don't rely on physical exam alone for volume assessment—use ultrasound when available 5
2. Don't measure ADH or natriuretic peptides—they don't change management 1
3. Don't fluid restrict in SAH patients with hyponatremia—it increases vasospasm risk 1
4. Don't use hypertonic saline in cirrhosis except for severe symptoms or pre-transplant—it worsens ascites 4
5. Don't correct chronic hyponatremia rapidly—osmotic demyelination can be worse than the hyponatremia itself 2, 10
6. Don't assume all hyponatremia in cirrhosis is hypervolemic—check for hypovolemia from diuretics 4, 6
7. Don't use vaptans long-term in cirrhosis—increased mortality demonstrated 4